{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:27:04Z","timestamp":1740634024375,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79703","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:47:03Z","timestamp":1740592023000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Adopting a Multidisciplinary Care Delivery Model on Treatment Effectiveness and Outcomes in Stage III Melanoma Patients at a Community-Based Academic Institution: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Zeeshan","family":"Hafeez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Nester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariharasudan","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Blackham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long GV","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM. Cutaneous melanoma. Lancet. 2023, 402:485-502. 10.1016\/S0140-6736(23)00821-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold M","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, et al.. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022, 158:495-503. 10.1001\/jamadermatol.2022.0160","journal-title":"JAMA Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0437-2_7","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter U","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014, 810:120-40. 10.1007\/978-1-4939-0437-2_7","journal-title":"Adv Exp Med Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States","volume":"156","author":"Paulson KG","year":"2020","unstructured":"Paulson KG, Gupta D, Kim TS, et al.. Age-specific incidence of melanoma in the United States. JAMA Dermatol. 2020, 156:57-64. 10.1001\/jamadermatol.2019.3353","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199311000-00002","article-title":"How much melanoma is caused by sun exposure?","volume":"3","author":"Armstrong BK","year":"1993","unstructured":"Armstrong BK, Kricker A. How much melanoma is caused by sun exposure?. Melanoma Res. 1993, 3:395-401. 10.1097\/00008390-199311000-00002","journal-title":"Melanoma Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis LE","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019, 20:1366-79. 10.1080\/15384047.2019.1640032","journal-title":"Cancer Biol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15586\/codon.cutaneousmelanoma.2017.ch7","article-title":"Surgical management of melanoma","author":"Joyce KM","year":"2017","unstructured":"Joyce KM. Surgical management of melanoma. Cutaneous Melanoma: Etiology and Therapy. Ward WH (ed): Exon Publications, Brisbane (AU); 2017. 91-100. 10.15586\/codon.cutaneousmelanoma.2017.ch7"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2014.07.001","article-title":"Workup and staging of malignant melanoma","volume":"94","author":"Kauffmann RM","year":"2014","unstructured":"Kauffmann RM, Chen SL. Workup and staging of malignant melanoma. Surg Clin North Am. 2014, 94:963-72. 10.1016\/j.suc.2014.07.001","journal-title":"Surg Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15586\/codon.cutaneousmelanoma.2017.ch8","article-title":"Radiation therapy for melanoma","author":"Shi W","year":"2017","unstructured":"Shi W. Radiation therapy for melanoma. Cutaneous Melanoma: Etiology and Therapy. Ward WH (ed): Brisbane (AU); 2017. 101-18. 10.15586\/codon.cutaneousmelanoma.2017.ch8"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont AM","year":"2018","unstructured":"Eggermont AM, Blank CU, Mandala M, et al.. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med. 2018, 378:1789-801. 10.1056\/NEJMoa1802357","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30139-5","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomized, double-blind, phase 3 trial","volume":"16","author":"Eggermont AM","year":"2015","unstructured":"Eggermont AM, Chiarion-Sileni V, Grob JJ. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomized, double-blind, phase 3 trial. Lancet Oncol. 2015, 16:522-30. 10.1016\/S1470-2045(16)30139-5","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber J","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, et al.. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017, 377:1824-35. 10.1056\/NEJMoa1709030","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomized, controlled, phase 3 trial","volume":"22","author":"Eggermont AMM","year":"2021","unstructured":"Eggermont AMM, Blank CU, Mandal\u00e0 M. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomized, controlled, phase 3 trial. Lancet Oncol. 2021, 22:643-54. 10.1016\/S1470-2045(21)00065-6","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S117945","article-title":"Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature","volume":"11","author":"Soukup T","year":"2018","unstructured":"Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JS. Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature. J Multidiscip Healthc. 2018, 11:49-61. 10.2147\/JMDH.S117945","journal-title":"J Multidiscip Healthc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3887-8","article-title":"The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis","volume":"158","author":"Battaglia TA","year":"2016","unstructured":"Battaglia TA, Darnell JS, Ko N, et al.. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat. 2016, 158:523-34. 10.1007\/s10549-016-3887-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07140-6","article-title":"The role of patient navigators in ambulatory care: overview of systematic reviews","volume":"21","author":"Budde H","year":"2021","unstructured":"Budde H, Williams GA, Winkelmann J, Pfirter L, Maier CB. The role of patient navigators in ambulatory care: overview of systematic reviews. BMC Health Serv Res. 2021, 21:1166. 10.1186\/s12913-021-07140-6","journal-title":"BMC Health Serv Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_236857","article-title":"The value and future developments of multidisciplinary team cancer care","volume":"39","author":"Selby P","year":"2019","unstructured":"Selby P, Popescu R, Lawler M, Butcher H, Costa A. The value and future developments of multidisciplinary team cancer care. Am Soc Clin Oncol Educ Book. 2019, 39:332-40. 10.1200\/EDBK_236857","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9040063","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala K","year":"2021","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci (Basel). 2021, 9:63. 10.3390\/medsci9040063","journal-title":"Med Sci (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313487-impact-of-adopting-a-multidisciplinary-care-delivery-model-on-treatment-effectiveness-and-outcomes-in-stage-iii-melanoma-patients-at-a-community-based-academic-institution-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:47:05Z","timestamp":1740592025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313487-impact-of-adopting-a-multidisciplinary-care-delivery-model-on-treatment-effectiveness-and-outcomes-in-stage-iii-melanoma-patients-at-a-community-based-academic-institution-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.79703","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}